Simon Witzel

11PUBLICATIONS
24CO-AUTHORS
Neurology and neuromuscular diseasesEpidemiological methodsClinical chemistry (incl. diagnostics)Rheumatology and arthritisGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 09, 2025
Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral Sclerosis.

Christina Steffke, Karthik Baskar, Franziska Bachhuber

|Apr 04, 2025
Population-Based Versus Hospital-Based Data in Amyotrophic Lateral Sclerosis-A Factor to Consider?

Johannes Dorst, Jens Dreyhaupt, Deborah Wernecke

|Aug 23, 2024
Population-Based Evidence for the Use of Serum Neurofilaments as Individual Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis.

Simon Witzel, André Huss, Gabriele Nagel

|Feb 22, 2024
Primary lateral sclerosis: application and validation of the 2020 consensus diagnostic criteria in an expert opinion-based PLS cohort.

Simon Witzel, Veronika Micca, Hans P Müller

|Jan 19, 2024
In-depth analysis of data from the RAS-ALS study reveals new insights in rasagiline treatment for amyotrophic lateral sclerosis.

Joachim Schuster, Jens Dreyhaupt, Karla Mönkemöller

|Nov 17, 2023
Longitudinal course of neurofilament light chain levels in amyotrophic lateral sclerosis-insights from a completed randomized controlled trial with rasagiline.

Simon Witzel, Jeffrey M Statland, Petra Steinacker

Pageof 2

Frequent Collaborators

5 joint publications

Johannes Dorst

3 joint publications

David Brenner

3 joint publications

Joachim Schuster

2 joint publications

Katharina Kandler